The NK-1 receptor is involved in the antitumoural action of L-733,060 and in the mitogenic action of substance P on human pancreatic cancer cell lines

Letters in Drug Design and Discovery

Volumn 3, Issue 5, 2006, Pages 323-329

  Muñoz, Miguel ^a   Rosso, Marisa ^a   Coveñas, Rafael ^b  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

CAPAN 1; Cell proliferation; NK 1 receptor antagonists; PA TU 8902; Pancreas adenocarcinoma; Tachykinins

Indexed keywords

3 [3,5 BIS(TRIFLUOROMETHYL)BENZYLOXY] 2 PHENYLPIPERIDINE; NEUROKININ 1 RECEPTOR; NEUROKININ 1 RECEPTOR ANTAGONIST; SUBSTANCE P;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CALORIMETRY; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL COUNT; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; COULTER COUNTER; CYTOTOXICITY TEST; DRUG DOSE REGIMEN; DRUG MECHANISM; HUMAN; HUMAN CELL; IC 50; IMMUNOBLOTTING; IN VITRO STUDY; MITOGENESIS; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PRIORITY JOURNAL;

EID: 33745590666     PISSN: 15701808     EISSN: None     Source Type: Journal    
DOI: 10.2174/157018006777574168     Document Type: Article

References (37)

1. Jemal, A.; Tiwari, R.C.; Murray, T.; Ghafoor, A.; Samuels, A.; Ward, E.; Feuer, E.J.; Thun, M.J. CA Cancer J. Clin., 2004, 54, 8.
2. Li, D.; Xie, K.; Wolff, R.; Abbruzzese, J.L. Lancet, 2004, 363, 1049.
3. von Euler, U.S.; Gaddum, J.H. J. Physiol., 1931, 72, 74.
4. Pernow, B. Pharmacol. Rev., 1983, 35, 85.
5. Hökfelt, T.; Pernow, B.; Wahren, J. J. Intern. Med., 2001, 249, 27.
6. Harrison, S.; Geppetti, P. Int. J. Biochem. Cell. Biol., 2001, 33, 555.
7. Luo, W.; Sharif, T.R.; Sharif, M. Cancer Res., 1996, 56, 4983.
8. Palma, C.; Nardelli, F.; Manzini, S.; Maggi, C.A. Br. J. Cancer, 1999, 79, 236.
9. Muñoz, M.; Pérez, A.; Rosso, M.; Zamarriego, C.; Rosso, R. Melanoma Res., 2004, 14, 183.
10. Muñoz, M.; Rosso, M.; Pérez, A.; Coveñas, R.; Rosso, C.; Zamarriego, C.; Soult, J.A.; Montero, I. Invest. Ophthalmol. Vis. Sci., 2005, 46, 2567.
11. Muñoz, M.; Rosso, M.; Pérez, A.; Coveñas, R.; Rosso, C.; Zamarriego C.; Piruat, J.I. Neuropeptides, 2005, 39, 427.
12. Friess, H.; Zhu, Z.; Liard, V.; Shi, X.; Shrikhande, S.V.; Wang, L.; Lieb, K.; Korc, M.; Palma, C.; Zimmermann, A.; Reubi, J.C.; Buchler, M.W. Lab. Invest., 2003, 83, 731.
13. Harrison, T.; Williams, B.J.; Swain, C.J.; Ball, R.G. Bioorg. Med. Chem. Lett., 1994, 4, 2545.
14. Rupniak, N.M.; Carlson, E.; Boyce, S.; Webb, J.K.; Hill, R.G. Pain, 1996, 67, 189.
15. Kramer, M.S.; Cutler, N.; Feighner, J.; Shrivastava, R.; Carman, J.; Sramek, J.J.; Reines, S.A.; Liu, G.; Snavely, D.; Wyatt-Knowles, E.; Hale, J.J.; Mills, S.G.; MacCoss, M.; Swain, C.J.; Harrison, T.; Hill, R.G.; Hefti, F.; Scolnick, E.M.; Cascieri, M.A.; Chicchi, G.G.; Sadowski, S.; Williams, A.R.; Hewson, L.; Smith, D.; Carlson, E.J.; Hargreaves, R.J.; Rupniak, N. M. J. Science, 1998, 281, 1640.
16. Varty, G.B.; Cohen-Williams, M.E.; Hunter, J.C. Behav. Pharmacol., 2003, 14, 87.
17. Rupniak, N.M.; Carlson, E.C.; Harrison, T.; Oates, B.; Seward, E.; Owen, S.; de Felipe, C.; Hunt, S.; Wheeldon, A. Neuropharmacology, 2000, 39, 1413.
18. Bang, R.; Sass, G.; Kiemer, A.K.; Vollmar, A.M.; Neuhuber, W.L.; Tiegs, G. J. Pharmacol. Exp. Ther., 2003, 305, 31.
19. Lang, K; Drell, T.L.; Lindecke, A.; Niggemann, B.; Kaltschmidt, C.; Zaenker, K.S.; Entschladen, F. Int. J. Cancer, 2004, 112, 231.
20. Muñoz, M.; Pérez, A.; Coveñas, R.; Rosso, M.; Castro, E. Arch. Ital. Biol., 2004, 142, 105.
21. Woll, P.J.; Rozengurt, E. Proc. Natl. Acad. Sci. USA, 1988, 35, 1859.
22. Langdon, S; Sethi, T.; Richie, A.; Muir, M.; Smyth, J.; Rozengurt, E. Cancer Res., 1992, 52, 4554.
23. Reeve, J.G.; Bleehen, N.M. Biochem. Bioph. Res. Com., 1994, 199, 1313.
24. Palma, C.; Bigioni, M.; Irrissuto, C.; Nardelli, F.; Maggi, C.A.; Manzini, S. Br. J. Cancer, 2000, 82, 480.
25. Tarkkanen, A.; Tervo, T.; Tervo, K.; Eränkö, L.; Eränkö, O.; Cuello, A.C. Ophthalmic. Res., 1983, 15, 300.
26. Lee, C.M.; Kum, W.; Cockram, C.S.; Teoh, R.; Young, J.D. Brain. Res., 1989, 488, 328.
27. Khare, V.K.; Albino, A.P.; Reed, J.A. J. Cutan. Pathol., 1998, 25, 2.
28. Singh, D.; Joshi, D.D.; Hameed, M.; Qian, J.; Gascón, P.; Maloof, P.B.; Mosenthal, A.; Rameshwar, P. Proc. Natl. Acad. Sci. USA, 2000, 97, 388.
29. Organist, M.L.; Harvey, J.P.; McGillis, J.P.; Payan, D.G. Biochem. Biophys. Res. Commun., 1988, 151, 535.
30. Parnet, P.; Mitsuhashi, M.; Turck, C.W.; Kerdelhue, B.; Payan, D.G. Brain. Behav. Immun., 1991, 5, 73.
31. van Ginkel, F.W.; Pascual, D.W. J. Neuroimmunol., 1996, 67, 49.
32. Caberlotto L.; Hurd Y.L.; Murdock, P.; Wahlin, J.P.; Melotto, S.; Corsi, M.; Carletti, R. Eur. J. Neurosci., 2003, 17, 1736.
33. Lowenfels, A.B.; Maisonneuve, P.; Cavallini, G.; Ammann, R.W.; Lankisch, P.G.; Andersen, J.R.; Dimagno, E.P.; Andren-Sandberg, A.; Domellof, L. N. Engl. J. Med., 1993, 328, 1433.
34. Shrikhande, S.V.; Friess, H.; di Mola, F.F.; Tempia-Caliera, A.; Conejo-García, J.R.; Zhu, Z.W.; Zimmermann, A.; Büchler, M.W. Pain, 2001, 91, 209.
35. Hennig, I.M.; Laissue, J.A.; Horisberger, U.; Reubi, J.C. Int. J. Cancer, 1995, 61, 786.
36. Seegers, H.C.; Hood, V.C.; Kidd, B.L.; Cruwys, S.C.; Walsh, D.A. J. Pharmacol. Exp. Ther., 2003, 306, 8.
37. Guha, S.; Eibl, G.; Kisfalvi, K.; Fan, R.S.; Burdick, M.; Reber, H.; Hines, O.J.; Strieter, R.; Rozengurt, E. Cancer Res., 2005, 65, 2738.